Medicine and Dentistry
Acute B-Cell Lymphoblastic Leukemia
85%
Acute Lymphoblastic Leukemia
42%
Acute Myeloid Leukemia
14%
Adult
42%
Adverse Event
25%
Age
17%
Allogeneic Stem Cell Transplantation
17%
Aplasia
27%
B Cell
70%
Bone Marrow
30%
Cells
42%
Chimeric Antigen Receptor
42%
Chimeric Antigen Receptor T-Cell
51%
Chimeric Antigen Receptor T-Cell Immunotherapy
10%
Clinical Trial
14%
Cord Blood
14%
Cytokine Release Syndrome
19%
down Regulation
10%
Engraftment
8%
Event Free Survival
38%
Follow up
8%
Genomic DNA
8%
Graft Versus Leukemia Effect
42%
Granulocyte Macrophage Colony Stimulating Factor
42%
Hypogammaglobulinemia
8%
Incidence
19%
Minimal Residual Disease
25%
Morphology
10%
Overall Survival
8%
Patient
100%
Pediatrics
42%
Prognosis
8%
Spontaneous Remission
38%
Survival Rate
10%
Synapsin I
28%
T Cell
53%
T Cell Activation
8%
Therapeutic Procedure
64%
Therapeutics
8%
Toxicity
85%
Tumor Protein
28%
Wilms' Tumor
28%
Young Adult
42%
Immunology and Microbiology
Antigen
42%
B Cell
42%
B Cell Development
14%
Dendritic Cell
42%
Humanized Mouse
14%
Integrase
14%
Interferon Type I
42%
Leukapheresis
14%
Monocyte
28%
NSG Mouse
14%
T Cell Development
14%